Sumeet Mody

Stock Analyst at Piper Sandler

(3.26)
# 279
Out of 5,293 analysts
54
Total ratings
77.50%
Success rate
42.72%
Average return
13 Stocks
Name Action Price Target Current % Upside Ratings Updated
ENFN Enfusion
Maintains: Neutral
10 12
11.12 3.42% 4 Dec 23, 2024
SEIC SEI Inv
Maintains: Neutral
58 66
77.3 -14.62% 4 Dec 20, 2023
GCMG GCM Grosvenor
Maintains: Overweight
9 10
13.31 -24.87% 2 Aug 10, 2023
KKR KKR & Co
Maintains: Overweight
59 70
117.83 -40.59% 4 Aug 8, 2023
BX Blackstone
Maintains: Overweight
107 115
142.78 -19.46% 7 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 13
9.67 34.44% 1 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
17 15
20.41 -26.51% 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
35 38
60.1 -36.77% 6 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
248 260
173.47 49.88% 11 Mar 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 23
16.52 39.23% 5 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 97
149.46 -35.1% 2 Feb 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 48
44.27 8.43% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
55 58
n/a n/a 4 May 2, 2022